Literature DB >> 7737086

Gene linkage of two-dimensional polyacrylamide gel electrophoresis resolved proteins from isogene families in Saccharomyces cerevisiae by microsequencing of in-gel trypsin generated peptides.

J Norbeck, A Blomberg.   

Abstract

The total cellular extract of proteins from the yeast Saccharomyces cerevisiae was resolved by preparative two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) where 500 micrograms was loaded per gel, and a number of proteins in isogene families were selected for microsequencing analysis. Peptides were generated from resolved proteins by in-gel trypsin digestion, and fractionated by reversed phase-high performance liquid chromatography (RP-HPLC). Subsequent sequencing of peptides yielded internal amino acid sequences which unambiguously identified the selected proteins spots as gene products from PCD1, ENO1, ENO2, ADH1, HXK2, TDH2, TDH3, SSB1 and SSB2. The chromatograms obtained from RP-HPLC of related proteins were utilized to distinguish discriminating peptide fractions. With this approach two out of four amino acid differences between Ssb1p and Ssb2p were allocated. We estimate that by pooling five preparative gels, at least one hundred protein spots in the 2-D pattern of S. cerevisiae will be obtained in sequencable amounts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737086     DOI: 10.1002/elps.1150160124

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  3 in total

1.  Growth of Escherichia coli K88 in piglet ileal mucus: protein expression as an indicator of type of metabolism.

Authors:  L Blomberg; L Gustafsson; P S Cohen; P L Conway; A Blomberg
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

2.  Global changes in protein synthesis during adaptation of the yeast Saccharomyces cerevisiae to 0.7 M NaCl.

Authors:  A Blomberg
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

3.  The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis.

Authors:  Nobuhiro Koyama; Yuriko Tokura; Daniela Münch; Hans-Georg Sahl; Tanja Schneider; Yoshio Shibagaki; Haruo Ikeda; Hiroshi Tomoda
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.